XWEL

XWELL, Inc.

Healthcare · Diagnostics & Research

$201.83 sample

+1.93 (+0.97%) 1D

Market cap

$1.17T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-04

Alerts

8

Price$201.83 -1.82% 3M daily closessample

208.30195.68

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: General Counsel
Oct 02INSInsider sell: 10% owner
Sep 25INSInsider sell: EVP, Operations
Sep 18INSInsider sell: 10% owner
Sep 10INSInsider sell: EVP, Operations
Sep 04SEC10-Q filed
Aug 27INSInsider sell: Chief Financial Officer
Aug 18INSInsider sell: EVP, Operations

Sign up to see the real XWEL record →

Company facts

SEC EDGAR registration

Name: XWELL, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Smart-money score: +38sample, -100 to +100
Reporting currency: USD

Who is positioning in XWEL

sample

Insiders: 17 insider transactions over 90 days, net selling, $853.0M
Congress: 1 members traded over 90 days
Institutions · 13F: 43 funds hold $19.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$48.9B +15.9% y/y

Q4 2024Q3 2026

Inventory$28.7B +12.2% y/y

Q4 2024Q3 2026

Accounts receivable$22.0B +21.2% y/y

Q4 2024Q3 2026

Total debt$56.3B +10.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $335.0B -10.0% 3M
Sample peer B: $218.2B +2.2% 3M
Sample peer C: $845.4B -1.1% 3M
Sample peer D: $634.8B +13.7% 3M
Sample peer E: $608.0B +9.3% 3M